NCCN Guidelines® & Clinical Resources
NCCN Guidelines®
Registration and Access to the NCCN Guidelines® is FREE. You must
Login or Register to access this information.
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) are posted with the latest update date and version number.
New! NCCN Guidelines® User System (GUS™) - Access an interactive version of the NCCN Guidelines with enhanced interfacing and functionality. NCCN is launching GUS™ with the following NCCN Guidelines: Cancer- and Chemotherapy-Induced Anemia, Chronic Myelogenous Leukemia, Multiple Myeloma, Prostate Cancer, and Systemic Light Chain Amyloidosis
.
NCCN Mobile Applications - Access the NCCN Guidelines anywhere and at anytime through free NCCN Guidelines mobile apps for iPhone and Android.
The NCCN Guidelines are copyrighted by the NCCN. All rights reserved. NCCN Guidelines and illustrations (including algorithms) may not be reproduced in any form for any purpose without the express written permission of the NCCN. Permissions Requests Section
View the NCCN Guidelines Panel Members individual disclosures
NCCN Guidelines for Treatment of Cancer by Site
You must Login or Register to access this information.
Acute Myeloid Leukemia
Anal Carcinoma
Bladder Cancer
- Bladder Cancer
- Upper Tract Tumors
- Urothelial Carcinoma of the Prostate
Bone Cancer
- Chondrosarcoma
- Ewing's Sarcoma
- Osteosarcoma
Breast Cancer 
- Noninvasive
- Invasive
- Phyllodes Tumor
- Paget’s Disease
- Breast Cancer During Pregnancy
- Inflammatory Breast Cancer
Cancer of Unknown Primary (See Occult Primary)
Central Nervous System Cancers
- Adult Low-Grade Infiltrative Supratentorial Astrocytoma/Oligodendroglioma (excluding pilocytic astrocytoma)
- Anaplastic Gliomas/Glioblastoma
- Adult Intracranial Ependymoma
- Adult Medulloblastoma and Supratentorial PNET
- Primary CNS Lymphoma
- Primary Spinal Cord Tumors
- Meningiomas
- Limited (1-3) Metastatic Lesions
- Multiple (>3) Metastatic Lesions
- Leptomeningeal Metastases
- Metastatic Spine Tumors
Cervical Cancer
Chronic Myelogenous Leukemia
Colon/Rectal Cancer
Colon Cancer
Rectal Cancer
Esophageal Cancer
Gastric Cancer
Head and Neck Cancers
- Cancer of the Lip
- Cancer of the Oral Cavity
- Cancer of the Oropharynx
- Cancer of the Hypopharynx
- Cancer of the Nasopharynx
- Cancer of the Glottic Larynx
- Cancer of the Supraglottic Larynx
- Ethmoid Sinus Tumors
- Maxillary Sinus Tumors
- Unresectable/Recurrent/Persistent Head and Neck Cancer
- Occult Primary
- Salivary Gland Tumors
- Mucosal Melanoma
Hepatobiliary Cancers
- Hepatocellular Carcinoma
- Gallbladder Cancer
- Intrahepatic Cholangiocarcinoma
- Extrahepatic Cholangiocarcinoma
Hodgkin Lymphoma
Kidney Cancer
Malignant Pleural Mesothelioma
Melanoma
Multiple Myeloma/Other Plasma Cell Neoplasms
Multiple Myeloma
Systemic Light Chain Amyloidosis
Waldenström's Macroglobulinemia / Lymphoplasmacytic Lymphoma
Myelodysplastic Syndromes
Neuroendocrine Tumors
- Carcinoid Tumors
- Islet Cell Tumors (Pancreatic Endocrine Tumors)
- Neuroendocrine Unknown Primary
- Adrenal Gland Tumors
- Pheochromocytoma
- Poorly Differentiated (High Grade or Anaplastic)/Small Cell
- Multiple Endocrine Neoplasia, Type 1
- Multiple Endocrine Neoplasia, Type 2
Non-Hodgkin's Lymphomas
- Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- Follicular Lymphoma
- Marginal Zone Lymphoma
- Mantle Cell Lymphoma
- Diffuse Large B-Cell Lymphoma
- Burkitt Lymphoma
- Lymphoblastic Lymphoma
- AIDS-Related B-Cell Lymphoma
- Primary Cutaneous B-Cell Lymphoma
- Peripheral T-Cell Lymphoma
- Mycosis Fungoides/Sézary Syndrome
- Adult T-Cell Leukemia/Lymphoma
- Extranodal NK/T- Cell Lymphoma, nasal type
- Post-Transplant Lymphoproliferative Disorders
- T-Cell Prolymphocytic Leukemia
- Hairy Cell Leukemia
Non-Melanoma Skin Cancers
Basal and Squamous Cell Skin Cancers
Dermatofibrosarcoma Protuberans
Merkel Cell Carcinoma
Non-Small Cell Lung Cancer
Occult Primary (Cancer of Unknown Primary)
Ovarian Cancer
- Epithelial Ovarian Cancer (including Fallopian Tube Cancer and Primary Peritoneal Cancer)
- Borderline Epithelial Ovarian Cancer (Low Malignant Potential)
- Less Common Ovarian Histologies
Pancreatic Adenocarcinoma
Primary Peritoneal Cancer (See Ovarian Cancer)
Prostate Cancer
Small Cell Lung Cancer
- Small Cell Lung Cancer
- Lung Neuroendocrine Tumors
Soft Tissue Sarcoma
- Extremity
- Retroperitoneal/Intra-Abdominal
- Gastrointestinal Stromal Tumors (GIST)
- Desmoid Tumors
Testicular Cancer
Thymomas and Thymic Carcinomas
Thyroid Carcinoma
- Nodule Evaluation
- Papillary Carcinoma
- Follicular Carcinoma
- Hürthle Cell Neoplasm
- Medullary Carcinoma
- Anaplastic Carcinoma
Uterine Neoplasms
- Endometrial Cancer
- Uterine Sarcoma
NCCN Guidelines for Detection, Prevention, & Risk Reduction
You must Login or Register to access this information.
Breast Cancer Risk Reduction
Breast Cancer Screening and Diagnosis
Cervical Cancer Screening
Colorectal Cancer Screening
Genetic/Familial High-Risk Assessment: Breast and Ovarian
- Breast and/or Ovarian Genetic Assessment
- Hereditary Breast and/or Ovarian Cancer
- Li-Fraumeni Syndrome
- Cowden Syndrome
Lung Cancer Screening
Prostate Cancer Early Detection
NCCN Guidelines for Supportive Care
You must Login or Register to access this information.
Adult Cancer Pain
Antiemesis
Cancer- and Chemotherapy-Induced Anemia
Cancer-Related Fatigue
Distress Management
Myeloid Growth Factors
Palliative Care
Prevention and Treatment of Cancer-Related Infections
Senior Adult Oncology
Venous Thromboembolic Disease
Order the latest flash drive of the Complete Library of NCCN Guidelines®.
Disclaimer
The NCCN Guidelines are a statement of consensus of the authors regarding their views of currently accepted approaches to cancer treatment. The recommendations regarding the uses and indications in the NCCN Compendium have been derived directly from the NCCN Guidelines. The NCCN Compendium represents neither an all-inclusive listing of every drug and biologic nor every appropriate use and indication for drugs and biologics. The NCCN Templates are peer reviewed statements of consensus of their authors derived from the NCCN Guidelines for the conditions the NCCN Templates address. The NCCN Templates are not exhaustive and do not represent the full spectrum of care or treatment options described in the NCCN Guidelines or the NCCN Compendium or include all appropriate approaches or combinations of drugs or biologics for the treatment of cancer. A NCCN Template does not constitute an order.
Help with Viewing the NCCN Guidelines
Please maximize your browser window to view these guidelines. Please
note that there may be a delay of several seconds to a minute or
more, depending on the speed of your connection, as the PDFs download
into your browser window.